Forma Therapeutics
Dedicated to transforming the lives of patients with rare hematologic diseases and cancers.
Watertown, United States
159 employees
Series D
Total: $142.50M
Biotechnology, Health Care +1
General Information
Get notified when Forma Therapeutics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Forma Therapeutics
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Forma Therapeutics
Taxonomy: biopharmaceutical, clinical-stage, rare diseases, cancer research, drug development, oncology, genomic medicine, biological insight, chemistry expertise, patient benefit, innovative drug discovery, cancer therapy, oncology drugs
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series D | •••••• | 6 |
|
19 Dec 2019 |
| Series C | •••••• | 2 |
|
07 Sep 2012 |
| Series B | •••••• | 2 |
|
17 Dec 2009 |
| Series B | •••••• | - | 01 Dec 2009 | |
| Series A | •••••• | - | 14 Apr 2008 |
Forma Therapeutics Alternatives & Competitors
Onconova is focused on discovering and developing novel products for patients with cancer.
An oncology biotherapeutics company
Delivering the promise of radiopharmaceuticals to patients.
FAQ About Forma Therapeutics
Don't just browse. Track.
Signal Tracker monitors Forma Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.